(2761 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Big changes in asthma treatment : GINA 2019
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Asma e alergia em Angola
-
Late onset T2 asthma – a case study
-
How to improve outcomes
-
Asthma: phenotypes to endotypes
-
Novel pharamacological targets
-
Elderly asthma
-
Exercise: induced asthma and rhinitis
-
Lung function testing
-
Assessment of adherence to treatment using mHealth
-
Updates in [severe] asthma in adults
-
Asthma management during the COVID-19 pandemics
-
Severe Asthma and COVID-19
-
Difficult to control asthma in children
-
Immunotherapy in severe asthma (AIT)
-
Asma e alergia em pandemia
-
AAAAI Practice Parameters
-
Difficult to control asthma in adults
-
Inflammatory biomarkers
-
The basics of severe asthma - biomarkers
-
Benralizumab in severe eosinophilic asthma… Or is it something else?
-
Potential biomarkers for diagnosis and treatment for CSU
-
Therapies for multiple-tree nut allergies
-
Impact of climate change on asthma exacerbations
-
GINA Guidelines Update
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Nasal allergen challenge
-
Implementation of telehealth in asthma management: trials and tribulations
-
Global impact of the COVID-19 on the environment
-
Elevated tryptase – Now what?
-
Bronchiectasis and severe asthma
-
Endotype-driven treatment in chronic rhinosinusitis
-
Evidence of immunotherapy on allergy prevention?
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
Launch of the Biological guidelines
-
Tezepelumab (anti-TSLP) in asthma
-
Impact of climate change on the immune system
-
Electronic Health in Severe Asthma
-
Epicutaneous immunotherapy for the treatment of food allergy: ready for the prime time?
-
Big data and cluster analysis: a real life perspective
-
What are the best end-points in AIT asthma trials - the clinician point of view?
-
Targeted approaches for asthma
-
Food industry perspective
-
May contain traces… management in children with food allergies
-
Viral infection and asthma
-
Role Viral reactivations
-
AI models
-
Alternaria-induced thunderstorm asthma: An unrecognised trigger
-
Oral food challenges thresholds for clinical reactions
-
Pediatric Asthma in Real Life (PeARL): addressing controversies in pediatric asthma
-
A patient with an acute reaction: recognize, document and treat
-
Virtual care, social media and mHealth for allergy management
-
Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Can we prevent the development of food allergy?
-
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
-
Plans of GARD in terms of surveillance after COVID
-
2'FL and LNnT shape the gut microbiome and metabolome in CMPA
-
Delabelling adults
-
Management of adverse reactions to biologics
-
Placeebo effect is an integrated part of the treatment of AIT (Pro & Con Session: Con)
-
Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations
-
Moisturisers for the primary prevention of food allergy
-
Autoimmunity in atopic diseases
-
Predicting adverse reactions to biologicals
-
The ‘allergy tool kit’ for the transition clinic
-
AIT in the pediatric population
-
Adherence: A challenge for Immunotherapy
-
Early biomarkers for severe drug hypersensitivity reactions
-
Over-the-counter allergy prevention weaning products
-
Epithelial cell barrier and allergic diseases
-
How to select and follow a biological for asthma and CRSwNP
-
Eosinophilic fasciitis, an unusual presentation
-
Entre US y Europa. La Experiencia de la Inmunoterapia en Mexico
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
Psychological support to peanut allergic children and their families
-
Wild-fires, pollution, climate change and other threats
-
Living with food allergy
-
Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab
-
Early life wheeze - risk factors for asthma in school age
-
E-cigarettes: mechanistic link to lung injury
-
Placebo effects is an integrated part of the treatment benefits of AIT (Pro & Con Session: Pro)
-
Alternative free-from foods to reach a balanced diet
-
Primary care in CRDs during COVID
-
How to evaluate lung function? Hands-on plus lecture
-
Risk assessment and active management of food allergy
-
Epitope mapping of the major allergen 2S albumin from pine nut
-
Social media and Allergies: how can we support our patients?
-
The dilemma of food allergy additives
-
Development of a childhood asthma prediction model using machine learning approaches
-
Food allergy - the beginners guide
-
The role of EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
-
Focus on Patient. Personalised therapy for severe asthma
-
Telemedicine and Tele-health
-
Management of CRS: Highlights of EPOS 2020
-
Management of CRS: Highlights of EPOS 2020
-
Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study
-
Phenotypes and Endotypes
-
Innate trained immunity: An evolutionary perspective
-
Interferon therapy in airway disease: prophylaxis is the new approach in exacerbation prevention?
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
The engineering-medicine interface
-
New insights in urticaria mechanisms
-
Unusual presentations of contact dermatitis
-
Scraping nasal cytology in the diagnostics of the respiratory tract diseases
-
Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients
-
Should we do patch testing in children with eczema?
-
Does human milk and its composition matter for development and prevention of allergies?
-
Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)
-
An update on food allergy
-
Microbiota in immune-based therapies
-
Is anaphylaxis really rare in children?
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Gut microbiome - based therapeutic approaches
-
Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis
-
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
Understanding parent preferences for paediatric allergy services
-
Can the birch pollen be more aggressive in the polluted environments?
-
The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
-
Efficacy of venom immunotherapy: How long should patients be treated?
-
Diagnosis of insect venom allergy: back to basics
-
Biomarkers and predictors of responses to biologicals in atopic dermatitis
-
An update on prevention of allergic diseases
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
How do allergens sensitize?
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Covid 19 and air pollution: is there a relationship?
-
Allergy to Kale
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
-
Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach
-
Is IgA a piece of the EoE puzzle?
-
Immunological basis of food aversion
-
Bronchial allergen challenge in the clinic
-
Can we identify patients at risk of life-threatening allergic reaction to food?
-
Dupilumab in paediatric patients with eosinophilic esophagitis
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Differential diagnosis
-
Role of antigen-presenting cells in tolerance and allergy
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Hand eczema during the COVID-19 pandemic
-
Preparing a grant: Dos and Don'ts
-
Tree nut allergy: path from national to global data
-
Challenges on the implementation of early introduction of allergenic foods
-
Quality of life in mastocytosis scale (QLMS) - the construction of the disease-specific questionnaire
-
Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy
-
BAT as a diagnostic tool in allergy to lipid transfer proteins (LTP)
-
Reduction in rescue medication use in patients treated with the 300IR house dust mite slit table
-
Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
-
Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations
-
Sustained unresponsiveness to tree nuts after low dose oral immunotherapy in children aged 9-24 months
-
How can we improve the quality of life of patients with severe food allergy?
-
Molecular immune biomarkers for protein-based and peptide immunotherapy
-
Allergy School Cork 2022 Abstract BookDownload Abstract Book
-
Introduction - why bacterial lysates in the treatment of allergic diseases? / Wprowadzenie – dlaczego lizaty bakteryjne w terapii schorzen alergicznych ?
-
Immune responses in desentitization and tolerance
-
Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
-
Update on drug allergy
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients
-
Vaccines for older adults: benefits and limitations
-
Route of exposure determines the immune response to food allergens
-
Vaccines- Is this the tool to end the pandemic?
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
EAACI Guidelines on environmental health
-
Structural biology of food allergens and cross reactivity
-
Dupilumab (anti-IL4Ra) in CRSwNP
-
Recognizing immediate reactions in contact dermatitis
-
What do we learn from subgroup analyses in phase-III trials?
-
Optimization of allergen immunotherapy care using an integrated eHealth environment
-
Large spectrum response to Dupilumab in a patient with atopic multimorbidity
-
Insight from translational research on oral tolerance induction through breast milk
-
The impact of the exposome on allergies and asthma – a global view on urbanisation, climate change and pollution
-
Current and future perspectives
-
What’s different about the adolescent brain?
-
Big Data Analysis: MetabolomicsView Presentation
-
Fecal transplantation: a safe and efficient treatment option for gut dysbiosis? (Pro & Con Session: Con)
-
Fecal transplantation: a safe and efficient treatment option for gut dysbiosis? (Pro & Con Session: Pro)
-
EAACI Guideline on NAR: does it need to be updated?
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Practical Course on Big data analysis: transcriptomics, metabolomics, CyTOF and flow cytometryView Presentation
-
Do adrenaline auto-injectors save lives?
-
Novel cell based assays in allergy diagnostics
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Exercise-induced urticaria and anaphylaxis
-
Food allergy: new allergens on the block
-
Environmental epigenomics of allergy
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Prevention of food allergy: where are we now?
-
Hypereosinophilic syndromes and autoimmunity
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
Skin care from birth for allergy prevention: results today
-
Molecular and structural considerations for aerosolization of food allergens
-
Personalized nutrition approach towards better QOL in Food Allergy
-
Should blood eosinophils tresholds guide patient selection for anti-IL5 biologicals? (Pro&Con Session: Pro)
-
Sleep patterns and development of children with atopic dermatitis
-
A system biology and machine learning approach to childhood asthma
-
Novel insight into development of allergic diseases
-
Trichinella spiralis infection associated with chronic spontaneous urticaria - case series
-
Understanding immunological mechanisms that confer a higher risk of allergy
-
Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience
-
FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review
-
Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Impaired olfaction: diagnostics and its role in diseases
-
Treating allergic patients during the COVID-19 pandemic
-
Probiotics and prebiotics: an on-going journey
-
Novel approaches of allergen immunotherapy
-
Disease burden and treatment of moderate-to-severe atopic dermatitis (AD) in children aged <12 years: results from 732 patients in the PEDISTAD observational study
-
Non-T2 directed biologicals
-
Durable reduction in hereditary angioedema (HAE) attack rates with berotralstat over 24 months: results from the phase 3 apeX-2 study
-
Immune modulation in local allergic rhinitis
-
Alergia molecular na seleção de extratos para imunoterapia aos ácaros
-
Immune response to Corona virus infection
-
Pru p 10: the polygalacturonase described as a new peach tree pollen allergen
-
Lesson learned from the pathogenesis of SARS-COV2
-
Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator
-
Skin test, drug provocation and laboratory tests: which ones and when?
-
Using the “atopic dermatitis yardstick” in clinical practice
-
Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents
-
Precision medicine and biomarkers of atopic dermatitis
-
Systematic review and meta-analyses on the accuracy of diagnostic tests for IgE-mediated food allergy
-
Precision medicine in immunodeficiency
-
Collective advocacy for action on CRDs
-
Characterization of the immunological properties of different β-glucans on myeloid dendritic cells
-
How to use social media in your professional practice: the clinician perspective
-
Urban green spaces - The exposure and allergenicity index
-
ÖGAI: Covid as best practice model to combine immunology and allergy
-
Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST
-
Novel therapeutic approaches targeting endotypes of severe airway disease
-
New and clinically relevant contact allergens
-
Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study
-
How to improve compliance of allergen immunotherapy in the clinic?
-
Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial
-
Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life
-
Bronchial allergen challenge in research
-
Basophil activation test results change in birch pollen sensitized patients during first season of immunotherapy
-
A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study
-
Pathogenic Th cell population disease induction model: - From the recruitment of eosinophils to the induction of fibrosis
-
Using BAT for differentiation between sensitization and allergy to alpha-gal
-
Basophil activation test in anaphylaxis to non-steroidal anti-inflammatory drugs – is it useful?
-
Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines
-
Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis
-
Good safety profile, efficacy and few withdrawals during oral immunotherapy with characterised GMP peanut protein in a real-world setting
-
Measles infection causes immune amnesia
-
Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis
-
Immune regulation in specific B cells in food allergy, tolerance and outgrowing children
-
Are drug provocation tests required before decision to desensitize?
-
The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer
-
Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases
-
Metabolome-wide association study (MWAS) in subjects with self-reported beta-lactam allergic reactions using the twinsUK cohort
-
Dynamic and Behavior of plane tree pollen and its relationship with Pla a 1 aeroallergen concentration in Évora (Portugal)
-
Cellular tests for the diagnosing and monitoring of allergy
-
Food diversity during the first year and risk of atopic eczema and food allergy up to 12 years of age
-
Environment and Immunology StandUp TalksSpeakers ...
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
Impacting quality of life with PALFORZIA
-
Efficacy and safety of ragweed SLIT-tablet from a large trial in children with allergic rhinoconjunctivitis
-
Update of the WAO anaphylaxis guidance
-
It looks like urticaria – but is it?
-
Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study
-
Is There A Place For Chlorhexidine In The European Baseline Series?
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
Extensively hydrolysed formula with two human milk oligosaccharides reduces rate of upper respiratory tract infections in infants with cow’s milk allergy
-
Mechanism and prevention of epicutaneous sensitization to food allergens
-
Implementing biomarkers in immunophenotyping of atopic dermatitis
-
Neuroimmunology and allergy
-
Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy
-
Developing an adolescent and young adult allergy service
-
Risk factors for conjunctivitis in atopic dermatitis patients treated with dupilumab: results from the bioday registry
-
Multiple myeloma exosomes suppress natural killer cells: Modification by omega-3 fatty acids
-
Air pollution and allergy: call for action!
-
Mechanisms of non IgE mediated food allergy
-
